CV Sciences (CVSI) Change in Receivables (2013 - 2026)

CV Sciences' (CVSI) quarterly Change in Receivables came in at -$22000.0 in Q1 2026, up 78.0% year-on-year from -$12359.6 in Q1 2025, and down 466.67% quarter-over-quarter from $6000.0 in Q4 2025.

CV Sciences (CVSI) Change in Receivables (2013 - 2026) Analysis & Trends

CV Sciences has disclosed Change in Receivables across 14 years of filings, most recently posting -$22000.0 for Q1 2026.

  • Change in Receivables for Q1 2026 came in at -$22000.0, up 78.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$46000.0 (up 46.51% YoY), and the FY2025 annual result was -$124000.0, down 247.62% from the prior year.
  • Change in Receivables came in at -$22000.0 for Q1 2026 at CV Sciences, down from $6000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $130000.0 in Q2 2024 to a low of -$1.1 million in Q1 2022.
  • The 5-year median for Change in Receivables is -$22000.0 (2026), against an average of -$87000.0.
  • Across the five-year window, Change in Receivables tumbled 724.06% in 2022 and soared 382.61% in 2024, its largest moves.
  • CV Sciences' Change in Receivables stood at $107000.0 in 2022, then tumbled by 332.71% to -$249000.0 in 2023, then soared by 141.37% to $103000.0 in 2024, then plunged by 94.17% to $6000.0 in 2025, then plunged by 466.67% to -$22000.0 in 2026.
  • The last three Change in Receivables figures came in at -$22000.0 (Q1 2026), $6000.0 (Q4 2025), and -$142000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -78.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 106.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -38.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 81.40 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 23.22 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 2.23 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 116.25 Mn
10 CV Sciences - - 1.56 Mn -22,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -22,000.00
Mar 31, 2026 -22,000.00
Dec 31, 2025 6,000.00
Dec 31, 2025 6,000.00
Sep 30, 2025 -142,000.00
Sep 30, 2025 -142,000.00
Jun 30, 2025 112,000.00
Jun 30, 2025 112,000.00
Mar 31, 2025 -100,000.00
Mar 31, 2025 -100,000.00
Dec 31, 2024 103,000.00
Dec 31, 2024 103,000.00
Sep 30, 2024 -219,000.00
Sep 30, 2024 -219,000.00
Jun 30, 2024 130,000.00
Jun 30, 2024 130,000.00
Mar 31, 2024 70,000.00
Mar 31, 2024 70,000.00
Dec 31, 2023 -249,000.00
Dec 31, 2023 -249,000.00